EARLY bNAb THERAPY IN SHIVAD8-EO–INFECTED RHESUS MACAQUES
Co-administration of the anti-HIV-1 bNAbs 10-1074 and 3BNC117 to SHIV-infected monkeys at days 3, 10, and 17 post-challenge led to long-term CD8+ T cell-mediated control of infection in half of the monkeys (Nishimura et al., Nature, 2017). A possible mechanism behind virus control is that bNAbs form immune complexes with SHIV, leading to its cross-presentation…